Yestar Healthcare Clarifies Valuation Basis for Advanced Materials Equipment Acquisition

Yestar Healthcare Holdings Co Ltd ( (HK:2393) ) has shared an announcement.

Yestar Healthcare Holdings has issued a supplemental announcement detailing the valuation basis for its recently disclosed acquisitions of production equipment for advanced materials manufacturing. The company engaged independent valuer Beijing Yingyue Asset Appraisal to confirm that the consideration for the equipment aligns with prevailing market value.

The valuer adopted the cost approach, rejecting market and income methods due to the lack of an active secondary market and high uncertainty over future income from the new asset group. Using replacement cost as of 15 October 2025 and adjusting for associated expenses and depreciation, the equipment was appraised at about RMB55.88 million, underscoring that the transaction terms are on normal commercial terms and supporting transparency for shareholders and potential investors.

The most recent analyst rating on (HK:2393) stock is a Sell with a HK$0.11 price target. To see the full list of analyst forecasts on Yestar Healthcare Holdings Co Ltd stock, see the HK:2393 Stock Forecast page.

More about Yestar Healthcare Holdings Co Ltd

Yestar Healthcare Holdings Company Limited is a Cayman Islands-incorporated company listed in Hong Kong, operating in the healthcare-related advanced materials and equipment sector. The group focuses on acquiring and deploying specialised production equipment and materials used in the manufacture of advanced materials, positioning itself within high-value, technology-driven segments of the healthcare and materials markets.

Average Trading Volume: 910,355

Technical Sentiment Signal: Sell

Current Market Cap: HK$249.3M

Learn more about 2393 stock on TipRanks’ Stock Analysis page.